.jpg?bc=ffffff&h=525&w=1000&hash=D31F75FDAC56CC2720413614AB3E8FA4)
.jpg?bc=ffffff&h=525&w=1000&hash=CA132C5EA417BAC18D3DE1BD5A719558)
.jpg?bc=ffffff&h=525&w=1000&hash=C38DB42AFA62E8CD2F95A3E4937B3D26)
.jpg?bc=ffffff&h=525&w=1000&hash=48DF085B8C46A249E7DB20B51071EBC5)
PolyU researchers actively collaborate with industry to translate their research outcomes and innovations into solutions that respond to the needs of society. A delegation comprising 18 senior management members of the Shanghai Pharmaceuticals Holding Co. (SPH), including Mr Cho Man, Executive Director and President, visited the University last Friday and were greeted by Dr Miranda Lou, PolyU Executive Vice President and Prof. Kwok-yin Wong, PolyU Vice President (Education). Prof. Tao Xiaoming, Acting Director of the PolyU Academy for Interdisciplinary Research and the research team from the Department of Applied Biology and Chemical Technology presented the University's latest research and technology developments in #medical fields. They also explored plans to deepen cooperation between the University and SPH.
SPH’s business covers industrial and commercial sectors, and the company is a leader in the areas of #medicine research and development, manufacturing, distribution and retail. SPH has been ranked a Global Top 500 company by US “Fortune” magazine since 2020; and has also been ranked as a 2022 Global Top 50 pharma company by “Pharmaceutical Executive” magazine.
| Research Units | PolyU Academy for Interdisciplinary Research |
|---|
